Previous studies report that cerebral ischemia models indicate that NF-κB’s actions are widely harmful and that animals treated with a pharmacological NF-κB inhibition exhibit efficient anti-inflammatory effects [44, 45]. The gene discussed is NFKB1; the disease is brain ischemia.